Hybridon Incorporated Company Profile

08:05 EST 24th November 2017 | BioPortfolio

Hybridon is a leader in the discovery and development of genetic drugs. These drugs are based on "antisense" technology which uses synthetic RNA and DNA that are designed to treat the underlying cause of disease by stopping or reducing the body's production of proteins that directly or indirectly cause disease. Hybridon also manufactures and sells synthetic RNA and DNA, also called oligonucleotides, to third parties on a contract basis. Hybridon's leadership in the antisense field is based on oligonucleotide technology it owns or exclusively licenses, including (a) new advanced chemistries, (b) sequence selection know-how, (c) drug development know-how, (d) innovations in the manufacturing process, (e) its fully integrated, large scale manufacturing facility and (f) its experience in manufacturing over 300 different compounds with various chemical modifications.


620 Memorial Drive
United States of America


Phone: 617 528 7000
Fax: 617 528 7001

News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [37 Associated Companies listed on BioPortfolio]

Hybridon Incorporated

Hybridon is a leader in the discovery and development of genetic drugs. These drugs are based on "antisense" technology which uses synthetic RNA and DNA that are designed to treat the underlyi...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...


Founded in 2008 by the Axis Biotec Brasil™ group (, PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....


COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

LCG Systems

Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) ...

More Information about "Hybridon Incorporated" on BioPortfolio

We have published hundreds of Hybridon Incorporated news stories on BioPortfolio along with dozens of Hybridon Incorporated Clinical Trials and PubMed Articles about Hybridon Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hybridon Incorporated Companies in our database. You can also find out about relevant Hybridon Incorporated Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antisense therapy
Most human diseases are caused by production of abnormal proteins or malfunctioning proteins.   Antisense therapy involves inhibiting production of these proteins.  When a gene is known to cause a specific disease and the genetic sequence ...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record